| Literature DB >> 34231823 |
Mariana Soares da Silva1, Meriane Demoliner1, Alana Witt Hansen1, Juliana Schons Gularte1, Flávio Silveira1, Fágner Henrique Heldt1, Micheli Filippi1, Vyctoria Malayhka de Abreu Góes Pereira1, Francini Pereira da Silva1, Larissa Mallmann1, Pietra Fink1, Luana Letícia da Silva2, Matheus Nunes Weber1, Paula Rodrigues de Almeida1, Juliane Deise Fleck1, Fernando Rosado Spilki1.
Abstract
Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of the variant in Manaus, Northern Brazil. The same male patient was reinfected by another B.1.1.28 variant, namely P.2, in March, 2021. The genomic analysis confirmed genetically significant differences between the two viruses recovered in both infections, the P.1 lineage in the first episode and P.2 in the reinfection. Due the very early detection of P.1, we have also investigated the circulation of P.1 in the same region by differential RT-qPCR, showing that this was an isolated case of P.1 at the time of detection, and this variant has disseminated and became prominent from late January to the end of March, 2021. SARS-CoV-2 recent reports of reinfection have raised critical questions on whether and how well a first infection protects against reinfection.Entities:
Year: 2021 PMID: 34231823 DOI: 10.1590/S1678-9946202163058
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846